5/31
08:51 am
cldi
Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
High
Report
Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
5/17
09:00 am
cldi
Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV
Medium
Report
Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV
5/14
04:16 pm
cldi
Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results [Yahoo! Finance]
Low
Report
Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results [Yahoo! Finance]
5/14
04:05 pm
cldi
Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results
Medium
Report
Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results
5/1
07:00 am
cldi
Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
Medium
Report
Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
4/23
07:04 am
cldi
Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on April 24 [Yahoo! Finance]
High
Report
Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on April 24 [Yahoo! Finance]
4/23
07:00 am
cldi
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24
High
Report
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24
4/19
04:05 pm
cldi
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
Medium
Report
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
4/16
08:31 am
cldi
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering
High
Report
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering
4/9
07:15 am
cldi
Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company's Novel Immunotherapies at the AACR Annual Meeting 2024 [Yahoo! Finance]
High
Report
Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company's Novel Immunotherapies at the AACR Annual Meeting 2024 [Yahoo! Finance]
4/9
07:00 am
cldi
Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024
High
Report
Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024
3/15
04:20 pm
cldi
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results [Yahoo! Finance]
Low
Report
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results [Yahoo! Finance]
3/15
04:05 pm
cldi
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results
Medium
Report
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results
3/11
07:35 am
cldi
Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer [Yahoo! Finance]
Medium
Report
Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer [Yahoo! Finance]
3/11
07:00 am
cldi
Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer
Low
Report
Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer